U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems
Go back to U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems| Abbott Laboratories (NYSE: ABT) | Delayed: 102.70 +0.09 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.61 | 52 Week High | $46.38 | |||
| Open | $102.27 | 52 Week Low | $36.00 | |||
| Day High | $102.92 | P/E | 68.47 | |||
| Day Low | $101.84 | EPS | $1.50 | |||
| Volume | 959,861 | |||||
